50-32-224. Specific dangerous drugs included in Schedule II. Schedule II consists of the drugs and other substances, by whatever official, common, usual, chemical, or brand name designated, listed in this section.
(1) Substances, vegetable origin or chemical synthesis. Unless specifically excepted or listed in another schedule, any of the following substances, whether produced directly or indirectly by extraction from substances of vegetable origin, independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:
(a) opium and opiate and any salt, compound, derivative, or preparation of opium or opiate, excluding apomorphine, dextrorphan, nalbuphine, naloxone, and naltrexone and their respective salts, but including the following:
(i) raw opium;
(ii) opium extracts;
(iii) opium fluid extracts;
(iv) powdered opium;
(v) granulated opium;
(vi) tincture of opium;
(vii) codeine;
(viii) ethylmorphine;
(ix) etorphine hydrochloride;
(x) hydrocodone;
(xi) hydromorphone;
(xii) metopon;
(xiii) morphine;
(xiv) oxycodone;
(xv) oxymorphone; and
(xvi) thebaine;
(b) any salt, compound, derivative, or preparation thereof that is chemically equivalent or identical with any of the substances referred to in subsection (1)(a) of this section, except that these substances do not include the isoquinoline alkaloids of opium;
(c) opium poppy and poppy straw;
(d) coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any salt, compound, derivative, or preparation thereof that is chemically equivalent or identical with any of these substances, except that these substances do not include decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine; and
(e) concentrate of poppy straw, the crude extract of poppy straw in either liquid, solid, or powder form that contains the phenanthrene alkaloids of the opium poppy.
(2) Opiates. Unless specifically excepted or listed in another schedule, any of the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan and levopropoxyphene excepted:
(a) alfentanil;
(b) alphaprodine;
(c) anileridine;
(d) bezitramide;
(e) dihydrocodeine;
(f) diphenoxylate;
(g) fentanyl;
(h) isomethadone;
(i) levomethorphan;
(j) levorphanol;
(k) metazocine;
(l) methadone;
(m) methadone-intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
(n) moramide-intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid;
(o) pethidine (meperidine);
(p) pethidine-intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
(q) pethidine-intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
(r) pethidine-intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
(s) phenazocine;
(t) piminodine;
(u) racemethorphan;
(v) racemorphan;
(w) sufentanil; and
(x) bulk dextropropoxyphene (nondosage forms).
(3) Stimulants. Unless specifically excepted or listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system:
(a) amphetamine, its salts, optical isomers, and salts of its optical isomers;
(b) phenmetrazine and its salts;
(c) methamphetamine, its salts, isomers, and salts of its isomers; and
(d) methylphenidate.
(4) Depressants. Unless specifically excepted or listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
(a) amobarbital;
(b) pentobarbital;
(c) phencyclidine; and
(d) secobarbital.
(5) Immediate precursors. Unless specifically excepted or listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances:
(a) immediate precursor to amphetamine and methamphetamine:
(i) phenylacetone;
(b) immediate precursors to phencyclidine (PCP):
(i) 1-phenylcyclohexylamine; and
(ii) 1-piperidinocyclohexanecarbonitrile (PCC).
(6) Hallucinogenic substances:
(a) dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a federal food and drug administration-approved drug product; and
(b) nabilone.
History: En. Sec. 7, Ch. 412, L. 1973; R.C.M. 1947, 54-307; amd. Sec. 2, Ch. 141, L. 1983; amd. Sec. 2, Ch. 36, L. 1991.